Ignite Creation Date:
2024-05-05 @ 5:01 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00364858
Status:
COMPLETED
Last Update Posted:
2015-04-03
First Post:
2006-08-15
Brief Title:
Safety and Efficacy of Cerezyme Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease
Sponsor:
Genzyme a Sanofi Company
Organization:
Sanofi
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Gaucher Disease Non-Neuronopathic Form |
| Gaucher Disease Type 1 |
| Cerebroside Lipidosis Syndrome |
| Glucocerebrosidase Deficiency Disease |
| Glucosylceramide Beta-Glucosidase Deficiency Disease |